TDP-43: From Alzheimer's Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy (Q90379423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

title

TDP-43: From Alzheimer's Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

Limbic-predominant age-related TDP-43 encephalopathy

13 April 2020

main subject

0 references

author name string

Wendi Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

Yongjian Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

Lin Tu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

Zhisheng Ba

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

Juan Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

Nanqu Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

Yong Luo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

publication date

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

Frontiers in Molecular Neuroscience

13 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 April 2020

copyright license

start time

28 February 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

1 reference

12 December 2020

The mitochondrial death/life regulator in apoptosis and necrosis

1 reference

12 December 2020

Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9

1 reference

12 December 2020

Structural diversity and functional implications of the eukaryotic TDP gene family

1 reference

12 December 2020

Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.

1 reference

12 December 2020

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage

1 reference

12 December 2020

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease

1 reference

12 December 2020

TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein

1 reference

12 December 2020

Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.

1 reference

12 December 2020

Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.

1 reference

12 December 2020

Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies

1 reference

12 December 2020

Classification and basic pathology of Alzheimer disease

1 reference

12 December 2020

Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology

1 reference

12 December 2020

TAR-DNA binding protein-43 and alterations in the hippocampus.

1 reference

12 December 2020

TDP-43 in aging and Alzheimer's disease - a review

1 reference

12 December 2020

β-Amyloid triggers ALS-associated TDP-43 pathology in AD models

1 reference

12 December 2020

A harmonized classification system for FTLD-TDP pathology

1 reference

12 December 2020

Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease

1 reference

12 December 2020

Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration

1 reference

12 December 2020

Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models

1 reference

12 December 2020

TDP-43: a new player on the AD field?

1 reference

12 December 2020

Mitochondria and ALS: implications from novel genes and pathways.

1 reference

12 December 2020

Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury

1 reference

12 December 2020

Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis

1 reference

12 December 2020

Prion-like properties of pathological TDP-43 aggregates from diseased brains

1 reference

12 December 2020

Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency

1 reference

12 December 2020

The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients

1 reference

12 December 2020

TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?

1 reference

12 December 2020

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

1 reference

12 December 2020

Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.

1 reference

12 December 2020

TDP-43 is a key player in the clinical features associated with Alzheimer's disease

1 reference

12 December 2020

Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

1 reference

12 December 2020

TDP-43 interaction with the intracellular domain of amyloid precursor protein induces p53-associated apoptosis

1 reference

12 December 2020

TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism

1 reference

12 December 2020

ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43.

1 reference

12 December 2020

Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old

1 reference

12 December 2020

TDP-43 pathology in the population: prevalence and associations with dementia and age.

1 reference

12 December 2020

Significance and limitation of the pathological classification of TDP-43 proteinopathy

1 reference

12 December 2020

Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease

1 reference

12 December 2020

The Role of TDP-43 in Alzheimer's Disease

1 reference

12 December 2020

Reactive oxygen species and mitochondria: A nexus of cellular homeostasis

1 reference

12 December 2020

Updated TDP-43 in Alzheimer's disease staging scheme

1 reference

12 December 2020

Mitochondrial Cristae: Where Beauty Meets Functionality.

1 reference

12 December 2020

The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity

1 reference

12 December 2020

TLR4 is a link between diabetes and Alzheimer's disease.

1 reference

12 December 2020

TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia

1 reference

12 December 2020

Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model

1 reference

12 December 2020

Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization

1 reference

12 December 2020

Tau in Alzheimer's disease: Mechanisms and therapeutic strategies

1 reference

12 December 2020

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation

1 reference

12 December 2020

Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72.

1 reference

12 December 2020

TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss

1 reference

12 December 2020

Drug candidates in clinical trials for Alzheimer's disease

1 reference

12 December 2020

TDP-43 stabilises the processing intermediates of mitochondrial transcripts

1 reference

12 December 2020

Amyloid β-42 induces neuronal apoptosis by targeting mitochondria

1 reference

12 December 2020

Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study

1 reference

12 December 2020

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis

1 reference

12 December 2020

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

1 reference

12 December 2020

TDP-43 post-translational modifications in health and disease

1 reference

12 December 2020

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

1 reference

12 December 2020

RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43

1 reference

12 December 2020

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

1 reference

12 December 2020

Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort

1 reference

12 December 2020

Targeting the Synapse in Alzheimer's Disease

1 reference

12 December 2020

Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression

1 reference

12 December 2020

TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease

1 reference

12 December 2020

Overexpression of human wtTDP-43 causes impairment in hippocampal plasticity and behavioral deficits in CAMKII-tTa transgenic mouse model

1 reference

12 December 2020

Identifiers

DOI

10.3389/FNMOL.2020.00026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32180703 AND SRC:MED&resulttype=core&format=json

13 April 2020

PubMed publication ID

32180703

1 reference